Two Sigma Ventures

Tracked participation in 3 Atlas companies, with 0 explicitly attributed leads.

3portfolio companies

7round participations

0lead positions

Oct 2024latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

TTTerray Therapeutics—Feb 2022 → Oct 20243 roundsParticipant—

AIAllen Institute for AIResearch orgsAllen Institute for AI (Ai2) is a Seattle-based nonprofit AI research institute founded in 2014 by the late Paul…$337MraisedRecent roundsNSF + NVIDIA public-private infrastructure award (NSF OMAI) · Aug 2025$152M · led by Allen Institute for AI (Ai2)partnership investment commitment (grant/donation-style joint investment) · Apr 2025$20M · Ai2, Google Cloudincubator fund (investment capital) · May 2023$30M · led by Madrona Venture GroupAllen Institute for AI—Jan 2020 → May 20232 roundsParticipant—

RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)Recursion—Jul 2019 → Sep 20202 roundsParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Oct 17, 2024TTTerray TherapeuticsSeries B$120M—Participant

Source ↗

May 10, 2023AIAllen Institute for AIResearch orgsAllen Institute for AI (Ai2) is a Seattle-based nonprofit AI research institute founded in 2014 by the late Paul…$337MraisedRecent roundsNSF + NVIDIA public-private infrastructure award (NSF OMAI) · Aug 2025$152M · led by Allen Institute for AI (Ai2)partnership investment commitment (grant/donation-style joint investment) · Apr 2025$20M · Ai2, Google Cloudincubator fund (investment capital) · May 2023$30M · led by Madrona Venture GroupAllen Institute for AIincubator fund (investment capital)$30M—Participant

Source ↗

Feb 15, 2022TTTerray TherapeuticsSeries A$60M—Participant

Source ↗

Sep 09, 2020RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries D (equity financing)$239M—Participant

Source ↗+1 ↗

Jan 17, 2020AIAllen Institute for AIResearch orgsAllen Institute for AI (Ai2) is a Seattle-based nonprofit AI research institute founded in 2014 by the late Paul…$337MraisedRecent roundsNSF + NVIDIA public-private infrastructure award (NSF OMAI) · Aug 2025$152M · led by Allen Institute for AI (Ai2)partnership investment commitment (grant/donation-style joint investment) · Apr 2025$20M · Ai2, Google Cloudincubator fund (investment capital) · May 2023$30M · led by Madrona Venture GroupAllen Institute for AIincubator fund (investment capital)$10M—Participant

Source ↗

Jul 15, 2019RRecursionScienceRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company developing an end-to-end, AI-native drug discovery and…$1.2BraisedRecent roundsPublic Offering (equity) · Jun 2024$200M · Public market investors (follow-on offering)PIPE / strategic investment (NVIDIA investment) · Jul 2023$50M · NVIDIADebt financing (credit facility / term loan) · Jan 2023$11.9M · led by Midcap Financial Trust (Midcap)RecursionSeries C$121M—Participant

Source ↗

UndatedTTTerray TherapeuticsSeed$20M—Participant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗+1 ↗

Source ↗

Oct 17, 2024TTTerray TherapeuticsSeries B$120M—Participant

Source ↗

Feb 15, 2022TTTerray TherapeuticsSeries A$60M—Participant

Source ↗

UndatedTTTerray TherapeuticsSeed$20M—Participant

Source ↗